LON:OCTP Oxford Cannabinoid Technologies (OCTP) Share Price, News & Analysis GBX 0.12 -0.01 (-4.17%) (As of 06/5/2024) Add Compare Share Share Stock Analysis Stock AnalysisChartInsider Trades About Oxford Cannabinoid Technologies Stock (LON:OCTP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OCTP alerts:Sign Up Key Stats Today's Range 0.12▼ 0.2050-Day Range 0.12▼ 0.1252-Week Range 0.05▼ 1.38Volume11.40 million shsAverage Volume9.33 million shsMarket Capitalization£1.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.Read More… Donald Trump can’t save you from this crisis (Ad)Elon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?Get the full details now. Receive OCTP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford Cannabinoid Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address OCTP Stock News HeadlinesOxford Cannabinoid Technologies (LON:OCTP) Shares Down 4.2% - Should You Sell?November 16, 2024 | americanbankingnews.comSnoop Dogg-Backed Cannabis Biotech Joins Forces With Former Google Experts To Boost AI Drug DiscoveryNovember 6, 2024 | benzinga.comDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?November 22, 2024 | Wide Moat Research (Ad)Oxford Cann Share ChatMay 24, 2024 | lse.co.ukOxford Cannabinoid to Delist from London Stock ExchangeMay 8, 2024 | marketwatch.comA bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London marketsMay 8, 2024 | msn.comOxford Cannabinoid Technologies Holdings PLCOctober 15, 2023 | wsj.comWeed In Europe: Medical Marijuana In Ukraine, Albania's Hemp, UK Cannabis Study Lacks DiversityOctober 12, 2023 | benzinga.comSee More Headlines OCTP Stock Analysis - Frequently Asked Questions How have OCTP shares performed this year? Oxford Cannabinoid Technologies' stock was trading at GBX 0.63 on January 1st, 2024. Since then, OCTP stock has decreased by 81.6% and is now trading at GBX 0.12. View the best growth stocks for 2024 here. How do I buy shares of Oxford Cannabinoid Technologies? Shares of OCTP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Oxford Cannabinoid Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Cannabinoid Technologies investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Brookfield Business Partners (BBU.UN), Bearing Lithium (BRZ), (BSFT) (BSFT), BTCS (BTCS) and BTC Digital (BTCTW). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OCTP CUSIPN/A CIKN/A Webwww.oxcantech.com Phone44 20 3034 2820FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-4,240,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-86.76% Return on Assets-53.92% Debt Debt-to-Equity RatioN/A Current Ratio3.32 Quick Ratio5.09 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,090,000,000Free FloatN/AMarket Cap£1.25 million OptionableNot Optionable Beta0.82 Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (LON:OCTP) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Cannabinoid Technologies Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Cannabinoid Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.